Home Featured Page 150

Featured

Latest

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

Whole-Body Effects of Psychedelics Part 3 – The Heart

Psyence Group Completes Export of Psilocybin Mushrooms to Portugal

Numinus to Participate in the Cantor Neurology & Psychiatry Conference on...

PT360 – Stephanie Wang – Kanna: Love and Wholeness Through Nature’s...

PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal...

Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive...

MindMed Announces Pricing of Public Offering of Common Shares and Warrants

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of...

MindMed Announces Proposed Public Offering of Common Shares

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on FDA, Election Year and ‘Ibogaine Exceptionalism’

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research, and the Future of Psychedelics

Gov. Spencer Cox Signs Utah’s H.B. 390 Into Law, Authorizing Psychedelic Research for Veterans With PTSD

ShroomskiCon 2026

Whole-Body Effects of Psychedelics Part 3 – The Heart

Psyence Group Completes Export of Psilocybin Mushrooms to Portugal

Numinus to Participate in the Cantor Neurology & Psychiatry Conference on...

PT360 – Stephanie Wang – Kanna: Love and Wholeness Through Nature’s...

PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal...

Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive...

MindMed Announces Pricing of Public Offering of Common Shares and Warrants

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of...

MindMed Announces Proposed Public Offering of Common Shares

EDITOR PICKS

Film Club: Music for Mushrooms

Psychedelic Approvals on Track, Advocacy in Flux: A Washington Dispatch on...

Betty Aldworth & Ismail Ali: MAPS Co-Executive Directors on Leadership, Research,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY